Corsens Medical has developed a lightweight, simple-to-operate, early-warning cardiac alert monitor for home use.Corsens received Pre-Marketing Notification (510(k)- K160656) clearance with the US FDA for its CPM.

After the successful completion of initial human clinical trials proving safety and effectiveness, the company is in the process of extending its clinical data in cooperation with hospitals in Israel and preparing its FDA-cleared device for commercialization.